Vascepa

What's next for Amarin? CEO John Thero talks Vascepa's label, pricing and future partnerships
Biopharma Dive
Sat, 11/16/19 - 10:35 pm
Amarin
Vascepa
John Thero
labeling
What's Next for Amarin's Stock?
Motley Fool
Fri, 11/15/19 - 10:41 am
Amarin
Vascepa
FDA
pharma stocks
advisory panels
FDA Advisory Committee Votes Unanimously in Favor of Expanding Amarin’s Vascepa Label
RAPS.org
Thu, 11/14/19 - 07:45 pm
FDA
advisory panel
Amarin
Vascepa
Shares of Amarin rise on favorable opinion from FDA committee
Marketwatch
Tue, 11/12/19 - 10:10 am
FDA
Amarin
Vascepa
The future of Vascepa sales, and Amarin, could hinge on next week's panel
EP Vantage
Tue, 11/5/19 - 10:28 am
Amarin
Vascepa
FDA
advisory panels
M&A
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
Endpoints
Fri, 10/18/19 - 10:18 am
ICER
drug pricing
JNJ
Xarelto
Amarin
Vascepa
Why Amarin Investors Have Their Eyes on Nov. 14
Motley Fool
Sun, 10/13/19 - 11:41 pm
Amarin
Vascepa
FDA
ESC 2019 – Amarin hopes for guideline boost despite regulatory delay
EP Vantage
Tue, 09/3/19 - 10:54 am
Amarin
Vascepa
ESC
European Society of Cardiology
Amarin's Vascepa buzzkill: FDA stalls label review with surprise panel meeting
Fierce Pharma
Thu, 08/8/19 - 11:36 pm
Amarin
Vascepa
advisory panels
FDA
Amarin boosted as another milestone to the FDA’s big Vascepa decision flies by with no sign of an AdCom
Endpoints
Wed, 07/31/19 - 10:30 am
FDA
Amarin
Vascepa
advisory panels
earnings
Acasti sits pretty as raise brings $400M for Amarin
BioWorld
Fri, 07/19/19 - 07:24 pm
Amarin
Vascepa
FDA
Acasti
Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push
Stat
Tue, 07/2/19 - 12:20 pm
Amarin
Vascepa
FDA
hirings
drug reps
Amarin gets a boost from the FDA as regulators promise speedy Vascepa decision — but what about that panel review?
Endpoints
Wed, 05/29/19 - 10:12 am
Amarin
Vascepa
FDA
Amarin defends Vascepa's CV-prevention data against supplement makers eager to cash in
Fierce Pharma
Wed, 05/8/19 - 10:51 am
Amarin
Vascepa
Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up
Endpoints
Fri, 03/29/19 - 10:02 am
Amarin
Vascepa
FDA
M&A
Diabetes group nods to Vascepa, sending Amarin stock higher
Biopharma Dive
Thu, 03/28/19 - 07:59 pm
ADA
Vascepa
Amarin
diabetes
Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
Stat
Mon, 03/18/19 - 12:14 pm
Amarin
Vascepa
American College of Cardiology
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Tue, 03/12/19 - 10:15 am
Bayer
heart failure
Amarin
Esperion
ACC
Vascepa
bempedoic acid
Is Amarin Sitting on a Goldmine?
Motley Fool
Thu, 02/28/19 - 09:18 pm
Vascepa
Amarin
Pharma's 2019 Prognosis Hinges on These Key Themes
Bloomberg
Wed, 01/2/19 - 09:48 pm
drug pricing
Amarin
Vascepa
IPOs
cancer

Pages